Navigation Links
Journal Article Suggests DermaClose® RC Used in Combination With VAC Therapy Can Dramatically Reduce the Need for Skin Grafting of Fasciotomy Wounds for Combat Related Trauma
Date:3/22/2012

CHANHASSEN, Minn., March 22, 2012 /PRNewswire-iReach/ -- Wound Care Technologies, Inc. (www.dermaclose.com), an emerging medical technology company, today announced the publication of an invited review article by MAJ Benjamin K. Potter, MD, LTC Brett A. Freedman, MD, and Michael S. Shuler, MD, at Walter Reed National Military Medical Center, Bethesda, MD, describing their treatment for closing extremity fasciotomy wounds using the DermaClose® RC Continuous External Tissue Expander as it applies to the treatment of traumatic war injuries.

The article entitled, "Fasciotomy Wound Management and Closure" appears in the current issue of Techniques in Orthopedics® (Volume 27, Number 1, Lippincott Williams & Wolters, www.techortho.com). The authors describe how the use of vacuum-assisted closure (V.A.C., Kinetic Concepts, Inc., San Antonio, TX) in combination with dermatotraction is their preferred method to positively influence the rate of delayed primary closure of extremity fasciotomy wounds. Paul J. Anderson, President and CEO of Wound Care Technologies, Inc. said, "Thi speer reviewed published article continues to demonstrate the significant role of continuous external tissue expansion in the treatment of traumatic injuries".

About DermaClose RC®
DermaClose® RC is a continuous external tissue expander that facilitates rapid tissue movement to reduce or re-approximate wounds. The first-of-its-kind device utilizes skin anchors and a tension controller that applies a continuous controlled dynamic pulling force and does not require additional tightening after initial application. The tension will be maintained from hours to days until desired amount of expanded tissue is achieved and the device is removed.

About Wound Care Technologies, Inc.
Wound Care Technologies, Inc. (www.woundcaretech.com) is an emerging medical device company focused on the commercialization of its novel continuous external tissue expansion technology. The DermaClose RC® is the companies initial product and is currently marketed in the United States. For further information please contact Mr. Dennis L. Davey, VP of Sales and Marketing via email at ddavey@woundcaretech.com.

Media Contact: Dennis Davey, Wound Care Technologies, Inc., 612-325-9736, Ddavey@woundcaretech.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Wound Care Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New England Journal of Medicine Article Reviews the Benefits of Ingenol Mebutate in Field Treatment of Actinic Keratoses
2. Generex Subsidiary Antigen Express Announces Publication of Review Showcasing its Proprietary Therapeutic Vaccine Technology in the Journal Vaccine
3. Data Published in the Journal of the American Society of Nephrology Shows Daily Home Hemodialysis Patients with the NxStage System One Have Significantly Lower Risk of Mortality and Improved 3-Year Survival Versus Patients on Conventional Hemodialys
4. Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism
5. Study Published in Neuro-Oncology Journal Shows Brain Tumor Eradication and Prolonged Survival in Mice Treated With Toca 511 and 5-FC
6. Aria Announces Publication of Independent Study in the American Journal of Obstetrics & Gynecology Using Arias Technology
7. National Pharmaceutical Council Debuts Column, "From Methods to Policy," In New Journal of Comparative Effectiveness Research
8. BioElectronics Study on Plantar Fasciitis to be Published in The Journal of Foot and Ankle Surgery
9. Results From Pilot Trial of PLCs RenalGuard® Published in International Journal of Cardiology
10. Journal of Cardiovascular Electrophysiology Study Shows Promising Single Ablation Procedure Outcomes With HeartLight EAS for Treatment of Atrial Fibrillation
11. OncoGenex Announces Publication of Phase I/II Custirsen (OGX-011/TV-1011) Data in Journal of Thoracic Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/8/2017)... Texas , June 8, 2017 /PRNewswire/ ... a leading developer and manufacturer of diagnostic ... announced today that Cressey & Company LP ... firm, has completed a growth-focused investment in ... a majority ownership position from selling shareholder, ...
(Date:6/5/2017)... The Cincinnati location of Diplomat Specialty ... has been awarded a Top Workplaces 2017 honor ... based on an employee survey administered by WorkplaceDynamics, LLC, a ... survey measures several aspects of workplace culture, including alignment, execution, ... ...
(Date:6/1/2017)... , June 1, 2017 Nutriceutical Holdings (NH), ... Recommended Solutions (VRS), and KD Pharma Group have decided ... Holdings by KD Pharma Group. KD Pharma Group will ... option to acquire the entire company. "We ... They are committed to growing the NH companies by ...
Breaking Medicine Technology:
(Date:6/26/2017)... ... June 26, 2017 , ... KICKICO , a protocol built on ... to solve many catastrophic issues within funding campaigns. KICKICO developers are testing the platform, ... crowdfunding - the raising of funds through the power of many - has been ...
(Date:6/25/2017)... ... 2017 , ... An increase in wetter weather in the Northern California area ... that; a humdinger of an allergy season. A relief from drought conditions is most ... grass and weed pollen. , “Our patients have been reporting the typical allergy ...
(Date:6/24/2017)... ... June 24, 2017 , ... The Pennsylvania Athletic Trainers’ ... Bayfront and Erie Convention Center on June 8-10. The weekend consisted of ... bowl, award and scholarship presentations, and professional networking. , On Friday June ...
(Date:6/23/2017)... ... June 23, 2017 , ... "The ... will ultimately do significant harm to people with all chronic conditions, including mental ... it leaves in place the Affordable Care Act (ACA) requirement that insurers cover ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... surgeon practicing in Newburgh, New York, has recently begun offering three new minimally ... offering the best cutting-edge procedures and reducing downtime, Dr. Rubinstein is excited to ...
Breaking Medicine News(10 mins):